CF
CNMD icon

Corebridge Financial’s CONMED CNMD Stock Holding History

Corebridge Financial’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,112
Closed -$973K – 597
2025
Q1 		$973K Sell
16,112
-316
-2% -$20.4K 0.01% 1270
2024
Q4 		$1.12M Sell
16,428
-1,279
-7% -$89.1K 0.01% 1281
2024
Q3 		$1.27M Sell
17,707
-187
-1% -$13.2K 0.01% 1245
2024
Q2 		$1.24M Buy
+17,894
New +$1.31M 0.01% 1229

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Corebridge Financial's CNMD Position: Q2 2025 in Review

Corebridge Financial sold out of CONMED (CNMD) in Q2 2025, closing a stake of 16,112 shares — an estimated $973K sold.

Corebridge Financial first reported a position in CNMD in Q2 2024 and held it in 4 quarters. The position peaked at $1.27M in Q3 2024. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Corebridge Financial reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 16,112 CONMED shares in Q2 2025, an estimated $973K.
  • Corebridge Financial first reported a position in CONMED in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's CONMED position peaked at $1.27M in Q3 2024.
  • 276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.